Memory performance in HIV/AIDS - A prospective case control study

Canadian Journal of Neurological Sciences

Volumn 34, Issue 2, 2007, Pages 154-159

  Odiase, Francis E ^a   Ogunrin, Olubunmi A ^a   Ogunniyi, Adesola A ^b  

^a UNIVERSITY OF BENIN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ATTENTION DISTURBANCE; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MEMORY; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; QUALITY OF LIFE; RESPONSE TIME; VERBAL MEMORY;

EID: 34347208621     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100005977     Document Type: Article

References (35)

1. Heaton RK, Grant I, Butters N, White DA, Kirson JH, Atkinson JH, et al. The HNRC 500 - neuropsychology of HIV infection at different disease stages - HIV Neurobehavioural Research Center. J Int Neuropsychol Soc. 1995;1:231-51.
2. Selnes OA. Memory loss in persons with HIV/AIDS: Assessment and strategies for coping. AIDS Reader. 2005;15(6):289-94.
3. McArthur JC, Sacktor N, Seines O. Human immunodeficiency virus-associated dementia. Semin Neurol. 1999;19:129-50.
4. Bacellar H, Munoz A, Miller EN, Cohen BA, Besley D, Seines OA, et al. Temporal trends in the incidence of HIV-1 related neurologic disease: multicenter AIDS cohort study, 1985-1992. Neurology. 1994;44:1892-900.
5. Perdices MA, Cooper DA. Simple and choice reaction time in patients with human immunodeficiency virus infection. Ann Neurol. 1989;25:460-7.
6. McArthur JC, Hoover DR, Bacellar H. Dementia in AIDS patients: incidence and risk factors. Neurology. 1993;43:2245-52.
7. Quinn TC. Global burden of the HIV pandemic. Lancet. 1996;348:99.
8. De Cock KM, Weiss HA. The global epidemiology of HIV/AIDS. Trop Med Intern Health. 2000;5:A3.
9. Moreland MC, Aldenkamp AP, DeAlpherts WCJ. A neuropsychological test battery for the Apple IIe. Int J of Man-Machine studies. 1986;25:453-67.
10. Moerland MC, Aldenkamp AP, Alpherts WCJ. Computerised psychological testing in epilepsy. In: Moarse FJ, Mulder LJM, Syouw WPB, Aldenkamp AP, editors. Computers in psychology, methods, instrumentation and psychodiagnostics. Lisse, USA. 1988. Swets and Zertlinger. p. 157-64.
11. Warrington, EK. Recognition Memory Test, NFER Nelson, Windsor, 1984.
12. Ogunrin O, Adamolekun B, Ogunniyi A, Aldenkamp AP. Cognitive functions in newly diagnosed Nigerians with epilepsy. Can J Neurol Sci. 2000;27(2):148-51.
13. Ferrando S, van Gorp W, McElhiney M, Goggin K, Sewell M, Rabkin J. Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS. 1998;12:F65-F70.
14. Van Gorp WG, Baerwald JP, Ferrando SJ, McElhiney MC, Rabkin JG. The relationship between employment and neuropsychological impairment in HIV infection. J Int Neuropsychol Soc. 1999;5:534-9.
15. Marcotte TD, Wolfson T, Rosenthal TJ, Heaton RK, Gonzalez R, Ellis RJ, et al. A multimodal assessment of driving performance in HIV infection. Neurology. 2004;63:1417-22.
16. Marcotte TD, Lazzaretto D, Scott JC, Roberts E, Woods SP, Letendre S, et al. Visual attention deficits are associated with driving accidents in cognitively-impaired HIV-infected individuals. J Clin Exp Neuropsychol. 2006;28:13-28.
17. Hinkin CH, Castellon SA, Durvasula RS, Hardy DJ, Lam MN, Mason KI, et al. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59:1944-50.
18. Tozzi V, Balestra P, Galgani S. Neurocognitive performance and quality of life in patients with HIV infection. AIDS Res Hum Retroviruses. 2003;19:643-52.
19. Justice AC, McGinnins KA, Atkinson JH, Heaton RK, Young C, Sadek J, et al. Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study. AIDS. 2004;18(suppl 1):S49-59.
20. Seines OA, Miller E, McArthur JC, Gordon B, Munoz A, Sheridan K, et al. HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. Neurology. 1990;40:204-8.
21. de Almeida SM, Letendre S, Ellis R. Human Immunodeficiency virus and the central nervous system. Braz J Infect Dis. 2006;10(1):41-50.
22. McArthur JC. NeuroAIDS: diagnosis and management. Hosp Pract. 1997;15:73-97.
23. Miller EN, Selnes OA, McArthur JC, Satz P, Becker JT, Cohen BA, et al. Neuropsychological performance in HIV-infected homosexual men: the multicenter AIDS cohort study (MACS). Neurology. 1990;40:197-203.
24. Clifford DB. AIDS dementia. Med Clin North Am. 2002;86:537-50.
25. Newman SP, Lunn S, Harrison MJG. Do asymptomatic HIV-seropositive individuals show cognitive deficit? AIDS. 1995;9:1011-220.
26. Miller EN, Satz P, Visscher BV. Computerized and conventional neuropsychological assessment of HIV-infected homosexual men. Neurology. 1991;41:1608-16.
27. White DA, Heaton RK, Monsch AU, HNRC Group. Neuropsychological studies of asymptomatic human immunodeficiency virus-type 1 infected individuals. The HNRC Group. HIV Neurobehavioural Research Center. J Int Neuropsychol Soc. 1995;1:304-15.
28. Martin A, Heyes MP, Salazar AM, Law WA, Williams J. Impaired motor-skill learning, slurred reaction time and elevated cerebrospinal fluid quinolinic acid in a subgroup of HIV-infected individuals. Neuropsychology. 1993;7:149-57.
29. Martin EM, Robertson LC, Edelstein HE, Jagust WJ, Sorenson DJ, San Giovanni D, et al. Performance of patients with early HIV infection on Stroop task. J Clin Exp Neuropsychol. 1992;14:857-68.
30. Basso MR, Bornstein RA. Effects of immunosuppression and disease severity upon neuropsychological function in HIV-infection. J Clin Exp Neuropsychol. 2000;22(1):104-14.
31. Selmaj KW, Raine SC. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol. 1988;12(3):339-46.
32. De SK, Marsh JW. HIV-1 Nef inhibits a common activation pathway in N1H-3T3 cells. J Biol Chem. 1994;269:6656-60.
33. Corasaniti MT, Bagetta G, Rotiroti D, Nistico G. The HIV envelope protein gp 120 in the nervous system: interactions with nitric oxide, interleukin-1BETA and nerve growth factor signaling, with pathological implications in vivo and in vitro. Biochemistry Phamacol. 1998;56:153-6.
34. Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M, Musisi S, et al. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology. 2006;67(2):311-4.
35. Suarez S, Baril L, Stankoff B, Khellaf M, Dubois B, Lubetzki C, et al. Outcome of patients with HIV-1 related cognitive impairment on highly active antiretroviral therapy. AIDS 2001;15(2):195-200.